The investment company has completed a tender offer, with only a small portion of shares being tendered. The company will retain £3.1 million in cash to support its new focus on robotics, AI and disruptive technologies.
The investment company announces changes to its board of directors, with the departure of two existing directors and the upcoming appointment of a new non-executive chairman and director.
The investment company is launching a Tender Offer to return up to £1.91 million to eligible shareholders through the repurchase of up to 86,826,818 ordinary shares.
The prominent investor has increased their stake in the company.
The asset management firm has announced a change in its major shareholding.
The investment company announces its upcoming AGM and proposed changes, including a tender offer and updates to its investing policy.
The investment firm provides an update on its portfolio company, highlighting positive operational and financial performance.
The investment firm has successfully exited its position in Oxford BioDynamics, generating a modest profit.
The investment firm reported a profit turnaround but faces headwinds from geopolitical uncertainty and constrained capital markets. Its shares trade at a significant discount to NAV, reflecting ongoing challenges.
The investment company provides an update on its portfolio holding, a global medicinal cannabis business with operations in Denmark and Australia.